We analyze complex RWD from NorstellaLinQ and other sources to provide actionable insights that address key business needs, inform strategic decisions, and offer a deeper understanding of market dynamics impacting therapeutic areas.
Project treatment patterns, dosing persistence, adherence, switches and dispense as written orders.
Understand trends in patient out-of-pocket costs and the correlation to utilization.
Define patient cohorts in your market and investigate their full patient journey.
Predict market share over time by segment, region, therapy line, specialty, or coverage type.
Translate complex, raw real-world data into comprehensive insights to inform decisions strategically.
Create a report of the key analyses that inform your team about their strategic direction.
Conduct readouts by MMIT experts to support organizational alignment.
Prioritize the findings that are most impactful to your brand.
Provide guidance on how to interpret the insights and determine next steps.
WHATS NEW
In this blog, our experts discuss how integrated data helps pharma brands identify patients, correct payer/IDN misalignment, and make better predictions to improve patient care.
For manufacturers, building a static commercialization strategy will only take you so far. Read this article on how to infuse real-world data in that strategy provides a more holistic view of the patient journey.
Hear from MMIT’s Lance Wolkenbrod about his conversations with manufacturers and the recurring themes he is hearing in this thought leadership piece that discusses the top five trends that are guiding pharma’s decisions about RWD today.
RELATED SOLUTIONS
MMIT’s RWD Visualizations solution combines coverage data and claims data to provide commercial pharma teams with a unique view of payer and prescriber behavior.
As the leading platform for pharma market access teams, MMIT Analytics analyzes comprehensive formulary, policy and restriction information to evaluate patient access for your brands, competitors and analogs.
RELATED SOLUTIONS
MMIT launch reports help manufacturers vet potential analog products, outline payer and channel segmentation, and highlight potential restrictions to drug launch policies, speeding up commercialization.
MMIT Landscape is an easy-to-navigate application that enables account managers to segment payers by market share, line of business, geographic reach and key relationship.
